Helle Knudsen

2.3k total citations
36 papers, 1.7k citations indexed

About

Helle Knudsen is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Helle Knudsen has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 10 papers in Molecular Biology. Recurrent topics in Helle Knudsen's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and HER2/EGFR in Cancer Research (6 papers). Helle Knudsen is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and HER2/EGFR in Cancer Research (6 papers). Helle Knudsen collaborates with scholars based in Denmark, Germany and Hungary. Helle Knudsen's co-authors include Peter E. Nielsen, Jens Overgaard, Marianne Kyndi, Flemming Brandt Sørensen, Marie Overgaard, Hanne Melgaard Nielsen, Bent Ejlertsen, Kirsten Vang Nielsen, Ann Knoop and Henning T. Mouridsen and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Helle Knudsen

35 papers receiving 1.7k citations

Peers

Helle Knudsen
Rose‐Marie Amini Sweden
Mohan Brahmandam United States
Sonia Fabris Italy
S Dirnhofer Switzerland
Roujun Peng China
Larissa V. Furtado United States
Christian Kurzeder Germany
Robert Königsberg Austria
Helena R. Chang United States
Eija Mahlamäki Finland
Rose‐Marie Amini Sweden
Helle Knudsen
Citations per year, relative to Helle Knudsen Helle Knudsen (= 1×) peers Rose‐Marie Amini

Countries citing papers authored by Helle Knudsen

Since Specialization
Citations

This map shows the geographic impact of Helle Knudsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helle Knudsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helle Knudsen more than expected).

Fields of papers citing papers by Helle Knudsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helle Knudsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helle Knudsen. The network helps show where Helle Knudsen may publish in the future.

Co-authorship network of co-authors of Helle Knudsen

This figure shows the co-authorship network connecting the top 25 collaborators of Helle Knudsen. A scholar is included among the top collaborators of Helle Knudsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helle Knudsen. Helle Knudsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliveira, Douglas V.N.P., Tobias Wirenfeldt Klausen, Anne Ortved Gang, et al.. (2021). High‐grade B‐cell lymphomas with MYC and BCL2 translocations lack tumor‐associated macrophages and PD‐L1 expression: A possible noninflamed subgroup. Hematological Oncology. 39(3). 284–292. 5 indexed citations
2.
Pedersen, Mette Ølgod, Anupama Reddy, Cassandra Love, et al.. (2019). PD‐L1 expression is low in large B‐cell lymphoma with MYC or double‐hit translocation. Hematological Oncology. 37(4). 375–382. 7 indexed citations
3.
Pedersen, Mette Ølgod, Anne Ortved Gang, Peter de Nully Brown, et al.. (2017). Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers. PLoS ONE. 12(10). e0186983–e0186983. 16 indexed citations
4.
Gang, Anne Ortved, Mette Ølgod Pedersen, Helle Knudsen, et al.. (2014). Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma. Leukemia & lymphoma. 56(7). 2039–2046. 10 indexed citations
5.
Nielsen, Signe Ledou, Helle Knudsen, Mats Ehinger, et al.. (2013). World Health Organization‐defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations—The Danish experience. American Journal of Hematology. 88(12). 1012–1016. 45 indexed citations
6.
Knudsen, Helle, et al.. (2011). Communicating Csr in the High Street Fashion Industry. 1 indexed citations
7.
Kyndi, Marianne, Flemming Brandt Sørensen, Helle Knudsen, et al.. (2008). Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group. Journal of Clinical Oncology. 26(9). 1419–1426. 432 indexed citations
8.
Kyndi, Marianne, Marie Overgaard, Hanne Melgaard Nielsen, et al.. (2008). High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiotherapy and Oncology. 90(1). 74–79. 82 indexed citations
9.
Kyndi, Marianne, Flemming Brandt Sørensen, Helle Knudsen, et al.. (2008). Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c. Acta Oncologica. 47(4). 608–617. 12 indexed citations
10.
Kyndi, Marianne, Flemming Brandt Sørensen, Helle Knudsen, et al.. (2008). Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials. Breast Cancer Research. 10(2). R24–R24. 16 indexed citations
11.
Nielsen, Kirsten Vang, Bent Ejlertsen, Susanne Möller, et al.. (2008). The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D. Acta Oncologica. 47(4). 725–734. 87 indexed citations
12.
13.
Olsen, Karen Ege, Helle Knudsen, Birgitte Rasmussen, et al.. (2004). Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes. Acta Oncologica. 43(1). 35–42. 61 indexed citations
14.
Knudsen, Helle. (1999). Irritant contact dermatitis caused by methyl iodide. American Journal of Contact Dermatitis. 10(2). 98–99. 1 indexed citations
15.
Knudsen, Helle & Peter E. Nielsen. (1997). Application of peptide nucleic acid in cancer therapy. Anti-Cancer Drugs. 8(2). 113–118. 37 indexed citations
16.
Helleberg, Carsten, Helle Knudsen, Kirsten Nikolajsen, et al.. (1997). CD34+ megakaryoblastic leukaemic cells are CD38−, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?. Leukemia. 11(6). 830–834. 14 indexed citations
17.
Knudsen, Helle & Peter E. Nielsen. (1996). Antisense Properties of Duplex- and Triplex-Forming PNAs. Nucleic Acids Research. 24(3). 494–500. 210 indexed citations
18.
Knudsen, Helle, C. B. Andersen, & S. D. Ladefoged. (1995). Expression of the intercellular adhesion molecule‐3 (ICAM‐3) in human renal tissue with relation to kidney transplants and various inflammatory diseases. Apmis. 103(7-8). 593–596. 6 indexed citations
19.
Knudsen, Helle, et al.. (1994). The role and use of ectomycorrhizal fungus biodiversity as an indicator of sustainable forestry. TAPPI Journal. 77(4). 57–59. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rose‐Marie Amini Breakdown of academic impact, for papers by Mohan Brahmandam Breakdown of academic impact, for papers by Sonia Fabris Breakdown of academic impact, for papers by S Dirnhofer Breakdown of academic impact, for papers by Roujun Peng Breakdown of academic impact, for papers by Larissa V. Furtado Breakdown of academic impact, for papers by Christian Kurzeder Breakdown of academic impact, for papers by Robert Königsberg Breakdown of academic impact, for papers by Helena R. Chang Breakdown of academic impact, for papers by Eija Mahlamäki
Rankless by CCL
2026